Vaccinate boys as well as girls against HPV: It works, and it may be cost effective

BMJ (Online)

Volumn 349, Issue , 2014, Pages

  Prue, Gillian ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

AUSTRALIA; CANADA; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MASS IMMUNIZATION; MEN WHO HAVE SEX WITH MEN; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PATIENT ATTITUDE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SHORT SURVEY; UNITED KINGDOM; UNITED STATES; UTERINE CERVIX CANCER; ADOLESCENT; ADULT; ARTICLE; CHILD; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; MALE; SEX DIFFERENCE; VACCINATION; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SEX FACTORS; VACCINATION; YOUNG ADULT;

EID: 84988850433     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g4834     Document Type: Short Survey

References (12)

1. Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 2011;364:401-11.
2. Newman PA, Logie CH, Doukas N, Asakura K. HPV vaccine acceptability among men: a systematic review and meta-analysis. Sex Transm Infect 2013;89:568-74.
3. Marty R, Roze S, Bresse X, Largeron N, Smith-Palmer J. Estimating the clinical benefits of vaccinating boys and girls against HPV related diseases in Europe. BMC Cancer 2013;13:10.
4. Burger EA, Sy S, Nygård M, Kristiansen IS, Kim JJ. Prevention of HPV related cancers in Norway: cost effectiveness of expanding the HPV vaccination program to include pre-adolescent boys. PLoS One 2014 20;9:e89974.
5. Public Health England. HPV vaccination programme schedule changing from 3 to 2 doses. 14 May 2014. www.gov. uk/government/news/hpv-vaccination-programme-schedulechanging-from-3-to-2-doses.
6. Public Health England. Annual HPV vaccine coverage 2012 to 2013: by PCT and SHA. 16 December 2013. www.gov. uk/government/publications/annual-hpv-vaccine-coverage-2012-to-2013-by-pct-and-sha.
7. Bowyer HL, Foster AS, Marlow LA, Waller J. Predicting human papillomavirus vaccination behaviour among adolescent girls in England: results from a prospective survey. J Fam Plann Reprod Health Care 2014;40:14-22.
8. Boyle T, Holmes A. Persistence and partnerships: school nurses, inequalities and the HPV vaccination programme. Br J School Nurs 2013;8:71-7.
9. Zou H, Tabrizi SN, Grulich AE, Garland SM, Hocking JS, Bradshaw CS, et al. Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. J Infect Dis 2014;209:642-51.
10. Baandrup L, Blomberg M, Dehlendorff C, Sand C, Andersen KK, Kjaer SK. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program. Sex Transm Dis 2013;40:130-5.
11. Baio G, Capone A, Marcellusi A, Mennini FS, Favato G. Economic burden of human papillomavirus related diseases in Italy. PLoS One 2012;7:e49699.
12. Desai S, Wetten S, Woodhall SC, Peters L, Hughes G, Soldon K. Genital warts and cost of care in England. Sex Transm Infect 2011;87:464-8.